94988 ⎘
Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Nitrogen atoms
SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS
#2COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION
#3DERIVATIVES OF KORORMICIN USEFUL AS ANTIBIOTICS
#4FUNCTIONALIZED MALEIMIDES AND ISOMALEIMIDES AND A PROCESS FOR PREPARATION THEREOF
#5ANTI-CANCER COMPOUNDS
#6Sulphonyl urea derivatives as NLRP3 inflammasome modulators
#7PANTETHENOYLCYSTEINE DERIVATIVES AND USES THEREOF
#8Anti-cancer compounds
#9Syntheses and uses of mechanism-based nutritional colorants from vitamin C and amino-containing compounds
#10Derivatives of korormicin useful as antibiotics
#11Inhibitors of Beta-Hydoxylase for Treatment of Cancer
#12Compositions and methods for viral sensitization
#13PHOTORESPONSIVE COMPOUND, ADHESIVE, SWITCHING MATERIAL, AND TONER CONTAINING THE PHOTORESPONSIVE COMPOUND, AND IMAGE FORMING METHOD USING THE TONER
#14Hepatitis B capsid assembly modulators
#15Isotopically-stabilized tetronimide compounds
#16Anti-cancer compounds
#17Inhibitors of Beta-Hydroxylase for Treatment of Cancer
#18Sulphonyl urea derivatives as NLRP3 inflammasome modulators
#19Amide compound or salt thereof, agricultural and horticultural microbicide comprising the compound and the salt, and method for using the agricultural and horticultural microbicide
#20INHIBITORS OF BETA-HYDROXYLASE FOR TREATMENT OF CANCER
#21Compositions and methods for viral sensitization
#22Derivatives of korormicin useful as antibiotics
#23Isotopically-stabilized tetronimide compounds
#24Photoelectric conversion element, optical sensor, imaging element, and compound
#25Inhibitors of beta-hydroxylase for treatment of cancer
#26Derivatives of korormicin useful as antibiotics
#27Biguanide compositions and methods of treating metabolic disorders
#28Modulators of indoleamine 2,3-dioxygenase
#29Inhibitors of β-hydroxylase for treatment of cancer
#30COMPOSITIONS AND METHODS FOR ENHANCING ONCOLYTIC VIRUS EFFICACY
#31Inhibitors of β-hydroxylase for treatment of cancer
#32Renewable cross-linker for increased bio-content from fructose
#33Compositions and methods for viral sensitization
#34Organic electroluminescent element, compound for use in the element, and light emitting device, display device, and illumination device using the element
#35Derivatives of korormicin useful as antibiotics
#36Inhibitors of beta-hydroxylase for treatment of cancer
#37Polymerizable compound and optically anisotropic object
#38Compound and organic photoelectric device, image sensor and electronic device including the same
#39Anti-endothelial lipase compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases
#40Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
#41Antifungal treatment
#42Disubstituted maleic anhydrides with altered kinetics of ring closure
#43Process and Intermediates for the Preparation of Pregabalin
#44Inhibitors of beta-hydroxylase for treatment of cancer
#45Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
#46Anti-cancer compounds
#47Compounds for treating proliferative disorders
#48Method for manufacturing compounds including nitrile functions
#49Biguanide compositions and methods of treating metabolic disorders
#50SMALL MOLECULE ANTI-FIBROTIC COMPOUNDS AND USES THEREOF
#51PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR
#52Phenyl-guanidine derivatives
#53Antifungal Treatment
#54Cycloalkyl guanidine FF-ATPase inhibitors and therapeutic uses thereof
#55Small molecule inhibitors of AGBL2
#56Substituted heterocyclic compounds for disease treatment
#57Lysophosphatidic acid receptor antagonists
#58Indene derivatives as pharmaceutical agents
#59COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL CONDITION(S) RELATED TO GPR35 AND/OR GPR35-HERG COMPLEX
#60Plasminogen activator inhibitor-1 inhibitor
#61Antifungal Treatment
#62GLP-1 receptor stabilizers and modulators
#631-heterodiene derivative and harmful organism control agent
#64Compounds for treating proliferative disorders
#65Group of amino substituted benzoyl derivatives and their preparation and their use
#66INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS
#67Photoelectric conversion material, film containing the material, photoelectric conversion device, production method thereof, photosensor, imaging device and their use methods
#68Process for the preparation of 4-aminobut-2-enolides
#69Indene derivatives as pharmaceutical agents
#70Amide and amidine derivatives and uses thereof
#71Indene derivatives as pharmaceutical agents
#72Compounds for treating proliferative disorders
#73Pyrene compounds and organic electroluminescent devices using the same
#74Thiosemicarbazones as anti-virals and immunopotentiators
#75Novel organic electroluminescent compounds and organic electroluminescent device using the same
#76BCRP/ABCG2 inhibitor
#77Heterocyclic substituted carbonyl derivatives and their use as dopamine Dreceptor ligands
#78Compounds effecting glucokinase
#79Anthranilic acid derivative or salt thereof
#80SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#81Furan Compounds Useful As Ep1 Receptor Antagonists
#82Substituted propiolic acid amides and their use for producing drugs
#83Dinaphthyl ethylene derivativce, process for preparing it, film prepared from it, and OLED including the film
#84Compounds effecting glucokinase
#85Stilbene derivatives and their use for binding and imaging amyloid plaques
#86Biaryl Derivatives
#87Modulation of Pathogenicity
#88Modulation of Pathogenicity
#89Modulation of Pathogenicity
#90Modulation of Pathogenicity
#91Modulation of Pathogenicity
#92Heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands
#93Novel 4-amino-2(5H)-furanones
#94Modulation of Pathogenicity
#95Aryl and heteroaryl compounds and methods to modulate coagulation
#96Asymmetric bis-hydroxyenamine compound, electrophotographic photoreceptor and image forming apparatus
#97Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof
#98Organic photoconductive material electrophotographic photoreceptor and image forming apparatus using the same
#99Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
#100Stilbene derivatives and their use for binding and imaging amyloid plaques
#101Furanone derivatives and methods of making same
#102Acceptor compounds useful for making hyperpolarizable organic chromophores
#103Antiproliferative agents
#104Antiproliferative agents
#105Benzylcycloalkyl amines as modulators of chemokine receptor activity
#106Compounds and methods
#107Oligofluorenlylene compounds
#108Pleuromutilin derivatives
#109Compounds effecting glucokinase
#110Thiosemicarbazones as anti-virals and immunopotentiators
#111Preparation of substituted butenolides via palladium-free etherification and amination of masked mucohalic acids
#112Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
#113Indene derivatives as pharmaceutical agents
#1143-cyano 4,5-diphenyl furan-2-carboxamides as antitubercular agents